Clinical trial

A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis

NCT00419666 · Galderma R&D, Industry · Completed

Key facts

NCT number NCT00419666
Title A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis
Official title PK and PD of Calcitriol Following Twice Daily Application of Calcitriol 3 µg/g Ointment Under Conditions of Maximal Use in Adolescents With Plaque Psoriasis
Lead sponsor Galderma R&D, Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Chronic Plaque Psoriasis
Intervention type Drug
Interventions Calcitriol 3mcg/g
Enrollment 25
Start date Aug 1, 2006
Primary completion Sep 24, 2009
Completion Sep 24, 2009
First posted Jan 9, 2007
Last update posted Feb 18, 2021
Countries Canada, United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies